Details for: CL0000788

Cell ID: CL0000788

Cell Name: naive B cell

Description: This cell type is compatible with the HIPC Lyoplate markers for 'naive B cell'. Per DSD: Naive B cells are also reportedly CD10-negative, CD19-positive, CD20-positive, CD21-positive, CD22-positive, CD25-negative, CD27-negative, CD34-negative, CD40-positive, CD43-negative, CD45-positive, CD48-positive, CD53-positive, CD80-negative, CD81-positive, CD84-positive, CD86-negative, CD95-negative, CD138-negative, CD150-positive, CD184/CXCR4-positive, CD185/CXCR5-positive, CD196/CCR6-positive, CD200-positive, CD229-positive, CD243-positive, CD289-positive, CD290-positive, CD352-positive, MHCII/HLA-DR-positive, cadherin 9-positive, and sIgH-positive, Transcription factors: Pax5-positive, ETS1-positive, FOXO1A-positive, KLF4-positive, KLF9-positive, MiTF-positive, OBF1-positive, PLZF-positive, and SpiB-positive.

Synonyms: naive B lymphocyte, naive B-cell, naive B-lymphocyte

Selected Context(s): Overall

Gene Significance Landscape

Display Options
Score:
Display
Genes

Contexts:

Cell Significance Index (CSI) is uniquely calculated to reveal cell-specific gene markers. More info here

Significant Genes List

Genes with the highest and lowest Percentile Rank Scores (PRS) for naive B cell within the selected context(s).

Gene ID: A unique numerical identifier for this specific gene.
Symbol: Shortened abbreviation or name that represents this gene.
Ensembl Gene ID: A unique identifier assigned by Ensembl for genomic data mapping.
CSI Score: A combined effect size and statistical significance measure for naive B cell. Higher scores indicate a stronger, more significant difference in expression.
(Previously described as "Fold Change", but now represents Cliff's Delta × –log10(p).)

Gene ID: A unique numerical identifier for this specific gene.
Symbol: Shortened abbreviation or name that represents this gene.
Ensembl Gene ID: A unique identifier assigned by Ensembl for genomic data mapping.
CSI Score: A combined effect size and statistical significance measure for naive B cell. Higher scores indicate a stronger, more significant difference in expression.
Average CSI: csi sum / gene count
Cell network configuration

This network visualizes key genes for naive B cell. It primarily includes:
1. Top genes highly significant for this cell (Num. Top Cell Genes - based on the 'Min. CSI' setting).
2. Any additional specific 'Context Genes' you add below.
The final network is a combined view. Choose an Interaction Source (pathways or protein interactions) and optionally compare CSI scores with a Baseline Cell Type.

Maximum number of selected genes.
Select a context for the baseline cell.
Select a context for the target cell.
Target Cell for CSI:  naive B cell (CL0000788)

 Legend
Nodes (Genes):
 Query Gene
Node size also reflects Target Cell CSI magnitude.
Node Color (Target Cell CSI in specific network):
 Very High
 High
 Medium
 Low
 Very Low
 N/A or Not Sig.
Edges (Interactions):
 STRING (Protein-Protein)
 ONTOLOGY (Shared Pathway)
 Colors vary by pathway category; default arrow applies.

Loading network (please wait)...

## Summary The [naive B cell](/details-cell/CL0000788), also known as a naive B-lymphocyte, is a mature B lymphocyte that has not yet encountered its cognate antigen. Based on its gene significance profile, this cell type is characterized by a state of metabolic and translational readiness, poised for rapid activation. **Overall**, the top markers highlight a robust machinery for antigen presentation (e.g., [CD74](/details-gene/972), [B2M](/details-gene/567)), high expression of specific mitochondrial respiratory components (e.g., [COX1](/details-gene/4512), [COX2](/details-gene/4513)), and abundant translational factors ([TPT1](/details-gene/7178), [PABPC1](/details-gene/26986)), all while expressing key anti-proliferative genes like [BTG1](/details-gene/694) that maintain its quiescent state. This signature suggests an actively maintained state of alert dormancy. ## Key Characteristics and Function Analysis of gene significance based on expression specificity (CSI Z-Score) reveals several functional clusters that define the [naive B cell](/details-cell/CL0000788). * **Antigen Presentation and Immune Surveillance:** The cell exhibits high expression specificity for multiple components of the antigen presentation pathway. These include [B2M](/details-gene/567), the light chain of MHC class I molecules, and [CD74](/details-e-gene/972), the invariant chain that chaperones MHC class II molecules. The high significance of other HLA genes like [HLA E](/details-gene/3133) and [HLA DPA1](/details-gene/3113) further solidifies the role of the [naive B cell](/details-cell/CL0000788) as a potential antigen-presenting cell (APC), capable of interacting with T cells even before its initial activation. * **Metabolic Poise and Bioenergetic Potential:** A prominent and defining feature is the high specificity score for numerous genes involved in mitochondrial oxidative phosphorylation. Top markers include multiple subunits of the cytochrome c oxidase complex ([COX1](/details-gene/4512), [COX2](/details-gene/4513), [COX4I1](/details-gene/1327), [COX7C](/details-gene/1350)) as well as components of other respiratory complexes like [CYTB](/details-gene/4519) and ATP synthase ([ATP5F1E](/details-gene/514)). This suggests that [naive B cells](/details-cell/CL0000788) maintain a highly active and specific mitochondrial profile, likely to meet the substantial energy demands required for clonal expansion and differentiation upon antigen encounter. * **Translational Readiness and Quiescence Maintenance:** The cell is defined by high expression of genes essential for protein synthesis and stability, such as the translationally controlled tumor protein ([TPT1](/details-gene/7178)) and translation elongation factors ([EEF1D](/details-gene/1936), [EEF1B2](/details-gene/1933)). This is counterbalanced by the significant expression of [BTG1](/details-gene/694), a transcription coregulator known for its anti-proliferative functions [Link](https://doi.org/10.1002/j.1460-2075.1992.tb05213.x). This paradoxical co-expression profile indicates that the cell is translationally prepared for rapid protein synthesis (e.g., antibodies) but is simultaneously held in a quiescent state by active regulatory mechanisms. * **Anti-Markers:** The negative CSI scores for other mitochondrial genes, including different cytochrome c oxidase subunits like [COX5B](/details-gene/1329) and [COX6C](/details-gene/1345), are particularly informative. This contrast with the highly-ranked COX subunits suggests that the composition of the respiratory chain complexes in [naive B cells](/details-cell/CL0000788) may be unique and specifically regulated, rather than reflecting a general upregulation of all mitochondrial components. ## Clinical Significance and Contextual Roles **Overall**, the gene profile of the [naive B cell](/details-cell/CL0000788) provides insights into its fundamental role in adaptive immunity and potential involvement in disease. The strong signature of antigen presentation genes ([CD74](/details-gene/972), [B2M](/details-gene/567), [HLA DPA1](/details-gene/3113)) underscores its importance in initiating immune responses. Dysregulation of these cells can contribute to both immunodeficiency (failure to respond to pathogens) and autoimmunity (inappropriate response to self-antigens). The anti-proliferative marker [BTG1](/details-gene/694) is a tumor suppressor, and its loss could be a factor in the development of B-cell malignancies. Furthermore, the high metabolic state indicated by the mitochondrial gene signature may represent a therapeutic vulnerability. Targeting metabolic pathways could be a strategy to modulate B-cell activation in autoimmune diseases or to inhibit the growth of B-cell cancers. The high specificity of genes involved in general protein synthesis and iron metabolism ([FTL](/details-gene/2512), [FTH1](/details-gene/2495)) highlights the foundational housekeeping processes that must be precisely controlled to maintain the vast pool of naive B cells and ensure their readiness. ## Potential Mechanisms and Research Directions 1. **Hypothesis:** The distinct pattern of mitochondrial gene expression, with high specificity for certain cytochrome c oxidase subunits ([COX1](/details-gene/4512), [COX2](/details-gene/4513)) and low specificity for others ([COX5B](/details-gene/1329), [COX6C](/details-gene/1345)), suggests that [naive B cells](/details-cell/CL0000788) assemble respiratory supercomplexes of a specific, non-canonical composition. This unique configuration may serve to optimize metabolic efficiency for long-term survival in a low-energy quiescent state while allowing for a rapid switch to high-output ATP production upon activation. * **Surprising Findings:** It is highly unusual for a quiescent lymphocyte to be defined by such a strong and specific mitochondrial signature. The dichotomy between highly and lowly expressed subunits of the same enzyme complex points towards a level of metabolic regulation in naive cells that is more sophisticated than previously appreciated. * **Testable Questions:** Can blue native PAGE or cryo-EM analysis reveal differences in the composition and structure of mitochondrial respiratory supercomplexes between [naive B cells](/details-cell/CL0000788) and their activated counterparts, such as plasmablasts? 2. **Hypothesis:** The co-expression of a robust translational machinery (high CSI for [TPT1](/details-gene/7178), [PABPC1](/details-gene/26986)) and a potent anti-proliferative regulator ([BTG1](/details-gene/694)) indicates that naive B-cell quiescence is an actively maintained, "revved" state rather than simple dormancy. [BTG1](/details-gene/694) may function as a critical brake, preventing cell cycle entry while the cell stockpiles the molecular machinery needed for immediate and explosive proliferation once that brake is released by antigen-receptor and co-stimulatory signals. * **Surprising Findings:** The concept of a cell being simultaneously repressed for proliferation yet primed for massive protein synthesis presents a compelling biological paradox. It suggests a highly efficient cellular design that minimizes response time upon activation. * **Testable Questions:** Does the targeted degradation of [BTG1](/details-gene/694) protein in [naive B cells](/details-cell/CL0000788) result in a lower threshold for activation and proliferation in response to suboptimal B-cell receptor stimulation, and does it affect the kinetics of antibody production?